RecruitingNot ApplicableNCT06063122

Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants


Sponsor

Thrive Neuromedical, LLC

Enrollment

203 participants

Start Date

Mar 8, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical study is to test a new, novel medical device designed to improve speech sound differentiation among hospitalized preterm infants. The device is designed to be used at an age equivalent to 32 weeks of gestation or older and to integrate readily into clinical practice for use by nurses and therapists staffing Level II to Level IV NICUs. Preterm born infants are at high risk for neurosensory impairments and developmental delays. In the NICU, infants are often deprived of infant-directed parental speech because of numerous challenges to parental visitation, resulting in reduced differentiation of speech sounds, altered brain structure and poor language outcomes. The study will explore the effectiveness of a novel medical device designed for infant learning through contingent sucking on a pacifier equipped with a sensor for suck pressure/timing, connected to a speaker that delivers mother's voice. The study will test the hypothesis that there will be a greater response difference between speech sounds on EEG, for infants receiving the suck-contingent mother's voice intervention than for infants hearing the same amount of non-contingent mother's voice from a speaker device.


Eligibility

Min Age: 32 WeeksMax Age: 35 Weeks

Inclusion Criteria1

  • CGA 32 0/7-35 0/7 weeks at study start, and GA 35 0/7 weeks at birth

Exclusion Criteria1

  • Ventilation using an endotracheal tube, major congenital malformations, family history of genetic hearing loss, and use of sedative/seizure medications (medications potentially masking ERP measured sensory processing) and severe white matter injury as it increases the likelihood of hearing deficits.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEsmallTalk NICU Active

The novel smallTalk NICU Active product design allows a disposable pacifier (equipped with the smallTalk sensor) to act as an infant-controlled mechanism for administration of developmentally appropriate parental voice, delivered by the NICU-safe speaker contingent upon the infant suck strength meeting an individually calibrated threshold.


Locations(2)

Emory University

Atlanta, Georgia, United States

Thrive Neuromedical, LLC

Chagrin Falls, Ohio, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06063122


Related Trials